Evidence map›Paper›PMID 21677456›Full record

ArticleOncology2011

End-of-life hospital costs in cancer patients: do advance directives or routes of hospital admission make a difference?

Tow S Tan, Aminah Jatoi

Abstract read
In one paragraph

Article in Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tow S TanDepartment of Oncology, Mayo Clinic, Rochester, Minn., USA.
Aminah Jatoi

Funding

Mentoring and Research in Cancer Palliative CareK24CA131099 · NCI · MAYO CLINIC ROCHESTER · PI JATOI, AMINAH · 2008 to 2012
$873k
NCI NIH HHS 5K24CA131099NCI NIH HHS K24 CA131099
6 · The paper itself

Abstract

objectiveEnd-of-life cancer care is costly. The current study explored whether advance directives or route of hospital admission reduced cancer patients' terminal hospitalization costs.

methodsThis single-institution study focused on solid tumor patients who died on an inpatient oncology service in 2008 and 2009. Patients' total costs were compared based on advance directives and route of hospitalization.

resultsAmong 120 patients, all except 4 had an incurable malignancy. Forty-six (38%) had an advance directive. Sixteen (13%) were admitted after an oncology clinic visit and 6 (5%) from hospice; others were admitted via other routes, most commonly from the emergency department. The median total cost for hospitalization (range) per patient was USD 12,962 (1,244-138,877). Patients with advance directives had no statistically significant difference in cost (p = 0.30), even after adjusting for age and time in the hospital. Those admitted after an oncology clinic or from hospice also had no difference in cost compared to those admitted via another route. Use of cardiopulmonary resuscitation, intensive care unit monitoring and intubation were similar between all compared groups.

conclusionAdvance directives and route of admission do not appear to impact the cost of terminal hospitalization for cancer patients.

Indexed as

AdultAdvance DirectivesAgedAged, 80 and overFemaleHospital CostsHospitalizationHumansMaleMiddle AgedMinnesotaNeoplasmsPatient AdmissionTerminal CareYoung Adult

Identifiers

PMID21677456
PMCPMC3128148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.